🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioAge Labs, Inc.

BIOA Healthcare
$16.81 $-0.05 (-0.30%)
Market Cap: $746.33 M
Gurus Holding
3
Popularity Rank
#3048
% of Shares Held
0.25%
Net Activity (Q4 2025)
-$889,691.17

Guru Ownership Trend

Guru Analysis for BioAge Labs, Inc. (BIOA)

BioAge Labs, Inc. (BIOA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.87 M.

Top institutional holders include Cliff Asness and Steven Cohen.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $889,691.17 net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 87.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$758,766.83
Total Buy Value
New Buys 1
Additions 1
-$1.65 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for BioAge Labs, Inc. (BIOA)

Major holders include Cliff Asness ($686,876), Steven Cohen ($544,811), Renaissance Technologies (RenTech) ($243,432). According to the latest reported data, 3 tracked investment managers collectively hold approximately 111,498 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $889,691.17, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited BIOA. The total reported sell value was $1.65 M.

Yes, 1 managers opened new positions in BIOA, and 1 increased their existing holdings. The total reported buy value was $758,766.83.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 45.2% 51,918 $686,876 Q4 2025
0.00% New Buy 41,180 $544,811 Q4 2025
0.00% Reduce -87.1% 18,400 $243,432 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form